Companies / MX1

MICRO-X LIMITED

ASX:MX1Health Care Equipment & Services
748.0M shares on issueASX (delayed) · as of 28 July 2026$0.030price · delayed$22.4Mmarket cap · indicative
D
Dilution grade

Runway under 2 quarters; share count grew 29% in 24 months; 4 cash raises in 24 months

Cash runway-0.1 quarters of funding
Share-count growth (24m)28.6%
Raise cadence (24m)4 cash raises
Options & rights overhang8.8% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

MICRO-X LIMITED's ordinary share count grew 28.6% between June 2024 and June 2026, to 748M shares. The company completed four capital raises in that period for total proceeds of A$25.1M, most recently a A$6.2M placement in December 2025. Options and rights on issue could convert into 66M new shares, equal to 8.8% of the current share count, with 0% in the money. At the March 2026 quarter the company reported A$-264K in available cash, equal to -0.1 quarters of funding at its recent spending rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
8.8%
Max option dilution
0.0%
ITM option dilution
2
Raises · last 12 months
-0.1 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 748.0M per ASX (delayed) (28 July 2026).
616.6M664.8M713.1MDec 24Sept 25July 26Cash raise · 15 Dec 2025Cash raise · 15 Dec 2025Cash raise · 13 Feb 2025Cash raise · 30 Jan 2025

Cash runway

-0.1 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
$-264k available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
30 June 20262A · quoted issueMX1 : ORDINARY FULLY PAID748.0MAppendix 2A
25 June 20262A · quoted issueMX1 : ORDINARY FULLY PAID748.0MAppendix 2A
1 June 20263H · cancellationMX1 : ORDINARY FULLY PAID729.2MAppendix 3H
19 May 20262A · quoted issueMX1 : ORDINARY FULLY PAID729.2MAppendix 2A
27 Apr 20262A · quoted issueMX1 : ORDINARY FULLY PAID729.2MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

4 cash raises in the last 24 months · 2 in the last 12 months

$6.2M
Placement
15 Dec 2025 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

8.8%
Total overhang · of current shares
0.0%
In the money · at current price
66.0M
Potential new shares
—
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
24 Apr 2026Patrick O'BrienOther2.5M——3Y notice
13 Jan 2026Ilona MeyerSell589k53k—3Y notice
8 May 2025Patrick O'BrienBuy1.4M——3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

7 July 2026Change in substantial holding
30 June 2026Change in substantial holding
30 June 2026MX1 - Notice Under Section 708A(5) of the Corporations Act
30 June 2026Application for quotation of securities - MX1
25 June 2026Application for quotation of securities - MX1
25 June 2026MX1 - Investor Presentation
16 June 2026MX1 - Notice Under Section 708A(5) of the Corporations Act
15 June 2026MX1 - Micro-X to Receive $1.3m for Lung CT Scanner Research
9 June 2026$PMX1 - Micro-X Completes Full Body CT Critical Design Review
3 June 2026MX1 - HealthInvest Presentation
3 June 2026$PMX1 - Human Imaging Study Commences with Micro-X Head CT
1 June 2026Notification of cessation of securities - MX1
1 June 2026Change in substantial holding
19 May 2026MX1 - Notice Under Section 708A(5) of the Corporations Act
19 May 2026Application for quotation of securities - MX1
18 May 2026$P$1.3m Checkpoint Contract Extension Awarded by DHS
30 Apr 2026$PMX1 - Quarterly Activities Report & Appendix 4C
27 Apr 2026Change of Director's Interest Notice - Patrick OBrien
27 Apr 2026MX1 - Notice Under Section 708A(5) of the Corporations Act
27 Apr 2026Application for quotation of securities - MX1

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.